Octagon Capital Advisors’s Kalaris Therapeutics KLRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$961K Sell
2025
Q1
$3.86M Sell
2024
Q4
$4.71M Buy
2024
Q3
$9.06M Buy
2024
Q2
$7.09M Buy
2024
Q1
$3.17M Buy